Vecuronium bromide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for vecuronium bromide and what is the scope of freedom to operate?

Vecuronium bromide is the generic ingredient in two branded drugs marketed by Organon Usa Inc, Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for vecuronium bromide. Ten suppliers are listed for this compound.

Summary for vecuronium bromide

US Patents:	0
Tradenames:	2
Applicants:	10
NDAs:	13
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	10
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	12
Patent Applications:	2,651
What excipients (inactive ingredients) are in vecuronium bromide?	vecuronium bromide excipients list
DailyMed Link:	vecuronium bromide at DailyMed

Recent Clinical Trials for vecuronium bromide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Renmin Hospital of Wuhan University	Phase 4
Fudan University	Phase 4
The Second Affiliated Hospital of Harbin Medical University	Phase 4

See all vecuronium bromide clinical trials

Pharmacology for vecuronium bromide

Drug Class	Nondepolarizing Neuromuscular Blocker
Physiological Effect	Neuromuscular Nondepolarizing Blockade

Medical Subject Heading (MeSH) Categories for vecuronium bromide

Neuromuscular Nondepolarizing Agents
Nicotinic Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for vecuronium bromide

M03AC	Other quaternary ammonium compounds
M03A	MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
M03	MUSCLE RELAXANTS
M	Musculo-skeletal system

US Patents and Regulatory Information for vecuronium bromide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	075549-002	Jun 13, 2000	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Meitheal	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	074688-002	Aug 25, 1999	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Labs Ltd	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	090243-001	May 11, 2010	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Eugia Pharma	VECURONIUM BROMIDE	vecuronium bromide	INJECTABLE;INJECTION	206670-002	Dec 20, 2018	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for vecuronium bromide

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-002	Apr 30, 1984	⤷ Sign Up	⤷ Sign Up
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-003	Jan 3, 1992	⤷ Sign Up	⤷ Sign Up
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-003	Jan 3, 1992	⤷ Sign Up	⤷ Sign Up
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-002	Apr 30, 1984	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.